We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Radcal IBA  Group

Download Mobile App




Guided Ablation System Treats Cardiac Arrhythmias

By HospiMedica International staff writers
Posted on 30 Aug 2021
A novel cardiac mapping and ablation platform enables examination and treatment of target tissues with precision and accuracy.

The CardioNXT (Westminster, CO, USA) platform is comprised of two physical tools, Axis wearable patient patches and the MultiLink internal reference catheter, both outfitted with electromagnetic and impedance sensors to identify the exact location of the tissue causing an arrhythmia. More...
Sensor readings are processed by the platforms iMap three dimensional (3D) Navigation & Mapping system and Activate software system so as to construct a 3D model of the heart, and also provide guidance during ablation procedures.

The iMap System uses dynamic referencing based 3D Navigation via a patented combination of dual tracking modalities (electromagnetic and impedance) that are generated by the proprietary internal reference MultiLink Catheter. During the subsequent cardiac ablation procedure, Activate software helps determine position coordinates for the surgical instruments in order to define precise location (relative to the constructed 3D heart model), and then guide the clinician safely towards the selected ablation site.

“CardioNXT has taken my advice to heart. I'm excited to see the improvements that can be made in the treatment of AFib patients with this technology. Treatment paradigms beyond PVI are still to be determined and we need systems like this one to help us evolve treatment strategies,” said Vivek Reddy, MD, director of cardiac arrhythmia service at Mount Sinai Hospital (New York, NY, USA). “My advice to all is that there must be a tight integration between complex mapping and accurate navigation in order for any map of the heart to be useful in the treatment of patients, especially complex cases such as persistent atrial fibrillation.”

AF ablation is a minimally invasive approach to create lesions (scar tissue) that interrupt irregular electrical signals in the heart, in a procedure known as pulmonary vein isolation (PVI). Since the pulmonary veins are often the major source of the cardiac arrhythmia, PVI via catheter ablation remains the cornerstone treatment for AF patients who are unresponsive to drug therapy.

Related Links:
CardioNXT


Platinum Member
STI Test
Vivalytic Sexually Transmitted Infection (STI) Array
Gold Member
Ultrasound System
FUTUS LE
Newborn Hearing Screener
ALGO 7i
Autoclave
Advance
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Surgical Techniques

view channel
Image: Professor Bumsoo Han and postdoctoral researcher Sae Rome Choi of Illinois co-authored a study on using DNA origami to enhance imaging of dense pancreatic tissue (Photo courtesy of Fred Zwicky/University of Illinois Urbana-Champaign)

DNA Origami Improves Imaging of Dense Pancreatic Tissue for Cancer Detection and Treatment

One of the challenges of fighting pancreatic cancer is finding ways to penetrate the organ’s dense tissue to define the margins between malignant and normal tissue. Now, a new study uses DNA origami structures... Read more

Patient Care

view channel
Image: The portable biosensor platform uses printed electrochemical sensors for the rapid, selective detection of Staphylococcus aureus (Photo courtesy of AIMPLAS)

Portable Biosensor Platform to Reduce Hospital-Acquired Infections

Approximately 4 million patients in the European Union acquire healthcare-associated infections (HAIs) or nosocomial infections each year, with around 37,000 deaths directly resulting from these infections,... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.